Skip to content
All news
General

Silver Economy Investing: Healthcare Giants in Focus

Healthcare giants such as Eli Lilly, Tandem Diabetes, Intuitive Surgical, and ResMed are tapping into aging-driven demand in obesity, surgery, and sleep care, offering long-term growth opportunities for investors.

May 19, 2026
2 min read
Source: Zacks
Share:

With the global population aging rapidly, the so-called "silver economy" is emerging as a promising investment opportunity. Major healthcare companies are capitalizing on this demographic trend by focusing on age-related diseases and conditions.

What is the Silver Economy?

The silver economy refers to economic activities and business opportunities arising from population aging. It encompasses healthcare, pharmaceuticals, medical devices, financial services, housing, and technology tailored for seniors.

Healthcare Giants Benefiting

According to a report from Zacks, several companies stand out:

  • Eli Lilly (LLY): Focuses on obesity treatments, a common condition among seniors that increases risks of chronic diseases.
  • Tandem Diabetes: Offers advanced diabetes management solutions, as diabetes prevalence rises with age.
  • Intuitive Surgical: A leader in robotic surgery, enabling less invasive procedures and faster recovery for older patients.
  • ResMed: Specializes in sleep apnea devices, a disorder common in aging populations.

Why This Matters for Investors

The silver economy represents a long-term structural trend, supported by rising life expectancy and declining birth rates. Companies addressing age-related health issues may see sustained demand and revenue growth.

What This Means for Investors

Investors can gain exposure through individual stocks like Eli Lilly and Abbott Laboratories, or via healthcare-focused ETFs. However, risks such as competition and regulatory changes should be considered.

Frequently Asked Questions

The silver economy refers to economic activities and business opportunities arising from population aging, including healthcare, pharmaceuticals, medical devices, and more.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.